Macular hole surgery is considered “bread and butter” for us vitreoretinal surgeons. The vast majority of macular holes will close with vitrectomy, usually with ILM peeling, and gas tamponade. A…
Let’s be honest, none of us decided to become vitreoretinal surgeons for the joys of coding our retinal procedures. However, with recent cuts across the board in surgical, diagnostic, and…
And now…finally…some good news in dry AMD! Geographic atrophy (GA) remains a significant unmet need that has been met with great attention by investigators and industry. However, until now, all…
Genentech reported yesterday that lampalizumab did not meet the primary endpoint in SPECTRI, one of the two parallel Phase III clinical trials investigating lampalizumab injections for the treatment of geographic…
The Surgical Technique section is one of the highlights of RETINA. New and innovative techniques are introduced in this section with accompanying surgical videos. It’s certainly a section that I…
In June, Novartis announced results from HAWK and HARRIER, two phase III clinical trials comparing brolocizumab (formerly RTH258) to aflibercept for the treatment of wet AMD. The primary endpoints were…
The final day of the ASRS annual meeting in Boston started off strong with hereditary retinal disease and genetic symposium. Next, Mark Humayan led an informative panel discussion reminding us…
Women in Retina: a profile of Zelia M. Correa, MD, PhD Interviewed by Nika Bagheri, MD What is your story? How did you become a retinal surgeon, ocular oncologist, and…